Health Press Release – Newsletter for February 8, 2011

The Sixth International Symposium on Molecular Insect Science to Feature Leading Researchers in the Field

Conference to be Held 2-5 October 2011, in the Netherlands
OXFORD, England, February 7, 2011 – Elsevier, the leading publisher of scientific, technical and medical
information products and services, announces that the Sixth International
Symposium on Molecular Insect Science is the first of the series to be held
outside the US. This year the conference will take place … Read the original article on Gaea Times at : The Sixth International Symposium on Molecular Insect Science to Feature Leading Researchers in the Field.

alli(R) Launching a New Chewable Tablet in 2011

LONDON, February 7, 2011 – GlaxoSmithKline (GSK) today announces that it has received a licence
extension for alli, the first pharmacy-only weight loss aid licensed for use
throughout Europe. This license extension is for new chewable tablets. The
new alli tablets are planned to be on sale in pharmacies throughout the UK in
April this year.

…. Read the original article  : here.

Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans

LONDON, NEW YORK and HAMILTON, Bermuda, February 7, 2011 – — Transfersome(R) Trans-Dermal Delivery System potentiates terbinafine's
anti-fungal activity in TDT 067 –

Celtic Pharmaceutical Holdings L.P. ("Celtic Pharma"), the global private
equity firm focused on the biotechnology and pharmaceutical industries,
announced today the presentation of key in-vitro data at the American Academy
of Dermatology …. Read the original article  : Celtic Pharma Announces Presentation of Preclinical Data at the 69th Annual Meeting of the AAD in New Orleans.

Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin

Product Already Filed With European Medicines Agency
STAINES, England, February 7, 2011 – Astellas Pharma Europe Ltd. announced today that it has entered into an
exclusive collaboration and license agreement with Optimer Pharmaceuticals
Inc., San Diego for the development and commercialisation of fidaxomicin, an
investigational antibiotic for Clostridium difficile infection (CDI) in
Europe and certain other countries in the … Read the original article on Gaea Times at : Astellas Enters into Partnership With Optimer on Life-Saving Antibiotic Fidaxomicin.

LighterLife and the National Obesity Forum Launch The UK Obesity Barometer

HARLOW, England, February 7, 2011 – LighterLife and the National Obesity Forum have launched The UK Obesity
Barometer to track weight gain in the UK.

The UK Obesity Barometer shows that around 1.2 million people in the UK
moved into the 'overweight' or 'obese' category over the festive season*
pushing levels to a new … Read more : LighterLife and the National Obesity Forum Launch The UK Obesity Barometer.

Health Robotics Re-Enters the Italian Market With its World-Leading Robotics and Software Automation Tools

BOZEN, Sud-Tirol, Italy, February 7, 2011 – Health Robotics today announced that it recently decided to re-start
sales and service operations in Italy, after a three-year absence in
connection with a prior agreement with Gruppo Loccioni. With over 60 hospital
customers under contract carried forward from the company's 2006-2007
presence in the Italian market, Health Robotics is on …. Original source  : Health Robotics Re-Enters the Italian Market With its World-Leading Robotics and Software Automation Tools.

Almac Opens Analytical Labs in New US Headquarters

SOUDERTON, Pennsylvania, February 7, 2011 – Almac's new 240,000 sq. ft. North American Headquarters, built on 40
acres in Souderton, PA, north of Philadelphia is part of the Almac Group's
integrated services solutions strategy. The new facility delivers
full-service, integrated clinical packaging, drug supply management and
technology solutions to pharmaceutical and biotech clients.

The facility [..] Read the original article: here.

ConvaTec Announces New Appointments to Leadership Team

Changes Align with Company's Commitment to Growth
SKILLMAN, New Jersey, February 7, 2011 – ConvaTec, a world-leading developer and marketer of innovative medical
technologies for community and hospital care, today announced the appointment
of several executives to new positions within the company.

Nino Pionati has been appointed President, Intercontinental in a newly
aligned region that … Read more >>>.

Fairfax Cryobank Announces Fairfax FaceMatch(TM) for Sperm Donors: Similar to System Used by the FBI, Computer Program Compares Photos to Find Resemblance

Fairfax Cryobank announces a new and exciting computer program to help patients "match" a photo of their partner or some other individual to find their perfect sperm donor

FAIRFAX, Virginia, February 7, 2011 – "Patients choosing donor sperm often wonder if they can find a donor who
resembles their partner or someone else. Fairfax Cryobank's new … Original article on : Fairfax Cryobank Announces Fairfax FaceMatch(TM) for Sperm Donors: Similar to System Used by the FBI, Computer Program Compares Photos to Find Resemblance.

PharmaMar Commences Clinical Trial in U.S. with New Antitumor Product, PM060184

PM060184 is a new marine-derived compound which has shown strong antitumor activity in preclinical models and a favorable safety profile in animal toxicology studies

MADRID, February 8, 2011 – PharmaMar SA (Grupo Zeltia, ZEL.MC) has announced the commencement of a
Phase I clinical trial with PM060184 for patients with solid tumors. PM060184
is a marine-derived synthetically-produced compound … Read more »».